Influence of Nitrosyl Iron Complex with Thiosulfate Ligands on Therapeutically Important Targets Related to Type 2 Diabetes Mellitus

The high prevalence of type 2 diabetes mellitus (T2DM), and the lack of effective therapy, determine the need for new treatment options. The present study is focused on the NO-donors drug class as effective antidiabetic agents. Since numerous biological systems are involved in the pathogenesis and p...

Full description

Bibliographic Details
Main Authors: Irina I. Faingold, Yuliya V. Soldatova, Darya A. Poletaeva, Elena N. Klimanova, Nataliya A. Sanina
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:Membranes
Subjects:
Online Access:https://www.mdpi.com/2077-0375/13/7/615
_version_ 1797588341511684096
author Irina I. Faingold
Yuliya V. Soldatova
Darya A. Poletaeva
Elena N. Klimanova
Nataliya A. Sanina
author_facet Irina I. Faingold
Yuliya V. Soldatova
Darya A. Poletaeva
Elena N. Klimanova
Nataliya A. Sanina
author_sort Irina I. Faingold
collection DOAJ
description The high prevalence of type 2 diabetes mellitus (T2DM), and the lack of effective therapy, determine the need for new treatment options. The present study is focused on the NO-donors drug class as effective antidiabetic agents. Since numerous biological systems are involved in the pathogenesis and progression of T2DM, the most promising approach to the development of effective drugs for the treatment of T2DM is the search for pharmacologically active compounds that are selective for a number of therapeutic targets for T2DM and its complications: oxidative stress, non-enzymatic protein glycation, polyol pathway. The nitrosyl iron complex with thiosulfate ligands was studied in this work. Binuclear iron nitrosyl complexes are synthetic analogues of [2Fe–2S] centers in the regulatory protein natural reservoirs of NO. Due to their ability to release NO without additional activation under physiological conditions, these compounds are of considerable interest for the development of potential drugs. The present study explores the effects of tetranitrosyl iron complex with thiosulfate ligands (TNIC-ThS) on T2DM and its complications regarding therapeutic targets in vitro, as well as its ability to bind liposomal membrane, inhibit lipid peroxidation (LPO), and non-enzymatic glycation of bovine serum albumin (BSA), as well as aldose reductase, the enzyme that catalyzes the reduction in glucose to sorbitol in the polyol pathway. Using the fluorescent probe method, it has been shown that TNIC-ThS molecules interact with both hydrophilic and hydrophobic regions of model membranes. TNIC-ThS inhibits lipid peroxidation, exhibiting antiradical activity due to releasing NO (IC50 = 21.5 ± 3.7 µM). TNIC-ThS was found to show non-competitive inhibition of aldose reductase with Ki value of 5.25 × 10<sup>−4</sup> M. In addition, TNIC-ThS was shown to be an effective inhibitor of the process of non-enzymatic protein glycation in vitro (IC50 = 47.4 ± 7.6 µM). Thus, TNIC-ThS may be considered to contribute significantly to the treatment of T2DM and diabetic complications.
first_indexed 2024-03-11T00:50:36Z
format Article
id doaj.art-29e28cf0e55748f7a3a87c4417b18f51
institution Directory Open Access Journal
issn 2077-0375
language English
last_indexed 2024-03-11T00:50:36Z
publishDate 2023-06-01
publisher MDPI AG
record_format Article
series Membranes
spelling doaj.art-29e28cf0e55748f7a3a87c4417b18f512023-11-18T20:25:49ZengMDPI AGMembranes2077-03752023-06-0113761510.3390/membranes13070615Influence of Nitrosyl Iron Complex with Thiosulfate Ligands on Therapeutically Important Targets Related to Type 2 Diabetes MellitusIrina I. Faingold0Yuliya V. Soldatova1Darya A. Poletaeva2Elena N. Klimanova3Nataliya A. Sanina4Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, Academician Semenov Avenue 1, Chernogolovka 142432, RussiaFederal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, Academician Semenov Avenue 1, Chernogolovka 142432, RussiaFederal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, Academician Semenov Avenue 1, Chernogolovka 142432, RussiaFederal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, Academician Semenov Avenue 1, Chernogolovka 142432, RussiaFederal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, Academician Semenov Avenue 1, Chernogolovka 142432, RussiaThe high prevalence of type 2 diabetes mellitus (T2DM), and the lack of effective therapy, determine the need for new treatment options. The present study is focused on the NO-donors drug class as effective antidiabetic agents. Since numerous biological systems are involved in the pathogenesis and progression of T2DM, the most promising approach to the development of effective drugs for the treatment of T2DM is the search for pharmacologically active compounds that are selective for a number of therapeutic targets for T2DM and its complications: oxidative stress, non-enzymatic protein glycation, polyol pathway. The nitrosyl iron complex with thiosulfate ligands was studied in this work. Binuclear iron nitrosyl complexes are synthetic analogues of [2Fe–2S] centers in the regulatory protein natural reservoirs of NO. Due to their ability to release NO without additional activation under physiological conditions, these compounds are of considerable interest for the development of potential drugs. The present study explores the effects of tetranitrosyl iron complex with thiosulfate ligands (TNIC-ThS) on T2DM and its complications regarding therapeutic targets in vitro, as well as its ability to bind liposomal membrane, inhibit lipid peroxidation (LPO), and non-enzymatic glycation of bovine serum albumin (BSA), as well as aldose reductase, the enzyme that catalyzes the reduction in glucose to sorbitol in the polyol pathway. Using the fluorescent probe method, it has been shown that TNIC-ThS molecules interact with both hydrophilic and hydrophobic regions of model membranes. TNIC-ThS inhibits lipid peroxidation, exhibiting antiradical activity due to releasing NO (IC50 = 21.5 ± 3.7 µM). TNIC-ThS was found to show non-competitive inhibition of aldose reductase with Ki value of 5.25 × 10<sup>−4</sup> M. In addition, TNIC-ThS was shown to be an effective inhibitor of the process of non-enzymatic protein glycation in vitro (IC50 = 47.4 ± 7.6 µM). Thus, TNIC-ThS may be considered to contribute significantly to the treatment of T2DM and diabetic complications.https://www.mdpi.com/2077-0375/13/7/615nitric oxidenitrosyl iron complexesmodel membraneliposomesmembranotropic propertiesanti-glycation activity
spellingShingle Irina I. Faingold
Yuliya V. Soldatova
Darya A. Poletaeva
Elena N. Klimanova
Nataliya A. Sanina
Influence of Nitrosyl Iron Complex with Thiosulfate Ligands on Therapeutically Important Targets Related to Type 2 Diabetes Mellitus
Membranes
nitric oxide
nitrosyl iron complexes
model membrane
liposomes
membranotropic properties
anti-glycation activity
title Influence of Nitrosyl Iron Complex with Thiosulfate Ligands on Therapeutically Important Targets Related to Type 2 Diabetes Mellitus
title_full Influence of Nitrosyl Iron Complex with Thiosulfate Ligands on Therapeutically Important Targets Related to Type 2 Diabetes Mellitus
title_fullStr Influence of Nitrosyl Iron Complex with Thiosulfate Ligands on Therapeutically Important Targets Related to Type 2 Diabetes Mellitus
title_full_unstemmed Influence of Nitrosyl Iron Complex with Thiosulfate Ligands on Therapeutically Important Targets Related to Type 2 Diabetes Mellitus
title_short Influence of Nitrosyl Iron Complex with Thiosulfate Ligands on Therapeutically Important Targets Related to Type 2 Diabetes Mellitus
title_sort influence of nitrosyl iron complex with thiosulfate ligands on therapeutically important targets related to type 2 diabetes mellitus
topic nitric oxide
nitrosyl iron complexes
model membrane
liposomes
membranotropic properties
anti-glycation activity
url https://www.mdpi.com/2077-0375/13/7/615
work_keys_str_mv AT irinaifaingold influenceofnitrosylironcomplexwiththiosulfateligandsontherapeuticallyimportanttargetsrelatedtotype2diabetesmellitus
AT yuliyavsoldatova influenceofnitrosylironcomplexwiththiosulfateligandsontherapeuticallyimportanttargetsrelatedtotype2diabetesmellitus
AT daryaapoletaeva influenceofnitrosylironcomplexwiththiosulfateligandsontherapeuticallyimportanttargetsrelatedtotype2diabetesmellitus
AT elenanklimanova influenceofnitrosylironcomplexwiththiosulfateligandsontherapeuticallyimportanttargetsrelatedtotype2diabetesmellitus
AT nataliyaasanina influenceofnitrosylironcomplexwiththiosulfateligandsontherapeuticallyimportanttargetsrelatedtotype2diabetesmellitus